95 %At day 14 after diagnosis, MPXV tests were negative or weakly positive in 20 (95%) of 21 urine samples.
NigeriampoxHAL · Unilimdocument de 102 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
168 evidences · page 1 / 7
95 %At day 14 after diagnosis, MPXV tests were negative or weakly positive in 20 (95%) of 21 urine samples.
NigeriampoxHAL · Unilimdocument de 102 observations
29 %MPXV detection was observed in 13 of 45 blood samples (29%).
NigeriampoxHAL · Unilimdocument de 102 observations
9 %At day 14, MPXV detection in anus was two [9%] of 22.
Nigeriampoxobservé day 14HAL · Unilimdocument de 102 observations
50 percentAll patients presented with skin lesions, with genital or anal involvement in about half of the cases.
NigeriampoxHAL · Unilimdocument de 102 observations
28 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 28 (80%) required hospital admission.
Nigeriampoxobservé October 21, 2021 to April 30, 2023publié 2025The Pan African medical journalPubMeddocument de 11 observations
124 confirmed_casesNigeria reported 124 confirmed mpox cases and zero deaths among confirmed cases in 2024.
Nigeriampoxobservé 2024Africa CDCdocument de 74 observations
78 %Seven (78%) of the nine mpox-related deaths were attributable to sepsis in Nigeria during the study period from Feb 1, 2022, to Jan 30, 2023.
Nigeriampox · sepsisobservé Feb 1, 2022, to Jan 30, 2023publié 2023The Lancet. Infectious diseasesPubMeddocument de 11 observations
1 180 suspected_casesNigeria reported 1,180 suspected mpox cases in 2024, with 78 confirmed cases across 24 states and the Federal Capital Territory.
Nigeriampoxobservé 2024Africa CDCdocument de 147 observations
71 %At day 0, MPXV detection was more frequent from anus (30 [71%] of 42) than from blood (13 [29%] of 45), urine (nine [22%] of 41), or semen (13 [54%] of 24).
Nigeriampoxobservé day 0HAL · Unilimdocument de 102 observations
100 %In a Spanish study, MPXV was detected in saliva in 100% of patients.
NigeriampoxHAL · Unilimdocument de 102 observations
5 %At day 14, MPXV detection was observed in 1 (5%) of 21 blood samples.
NigeriampoxHAL · Unilimdocument de 102 observations
6 countriesAs of 05 September 2024, six countries were experiencing sustained human-to-human mpox transmission: the Democratic Republic of the Congo, Burundi, Nigeria, South Africa, Cote d’Ivoire, and the Central African Republic.
Afrique du Sud · Burundi · Nigeria · RDCmpoxobservé 05 September 2024Africa CDCdocument de 48 observations
3 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 3 (8.6%) resulted in death.
Nigeriampoxobservé October 21, 2021 to April 30, 2023publié 2025The Pan African medical journalPubMeddocument de 11 observations
11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.
Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobservé February 2025Africa CDCdocument de 110 observations
9 casesDuring the 2017/2018 Nigerian mpox outbreak, 9 out of 40 hospitalized mpox patients with known HIV status were people living with HIV.
Nigeriampoxobservé 2017/2018publié 2023AIDS research and human retrovirusesPubMeddocument de 4 observations
6 patientsIn an English series, MPXV was detected in blood from six of seven patients at least once at the beginning of the disease.
NigeriampoxHAL · Unilimdocument de 102 observations
6 %Nine (6%) of the 160 patients with mpox died during the study period from Feb 1, 2022, to Jan 30, 2023 in Nigeria.
Nigeriampoxobservé Feb 1, 2022, to Jan 30, 2023publié 2023The Lancet. Infectious diseasesPubMeddocument de 11 observations
22 %At day 0, MPXV detection was less frequent from urine (nine [22%] of 41) than from skin, anus, or throat.
Nigeriampoxobservé day 0HAL · Unilimdocument de 102 observations
19,8 CtMPXV viral load was significantly higher from skin lesions (Ct 19·8) than from throat (Ct 27·2), blood (Ct 32·8), or semen (Ct 27·8).
NigeriampoxHAL · Unilimdocument de 102 observations
71 %In this case series, a high proportion of MPXV-positive oral and anal swabs (71–77%) was found at diagnosis.
NigeriampoxHAL · Unilimdocument de 102 observations
88 %MPXV detection was more frequent from skin samples (44 of 50, 88%) than from blood (13 of 45, 29%), urine (9 of 41, 22%), or semen (13 of 24, 54%).
NigeriampoxHAL · Unilimdocument de 102 observations
22 %In this case series, a lower proportion of positive blood and urine samples (22–31%) was found at diagnosis.
NigeriampoxHAL · Unilimdocument de 102 observations
60 %Three-fifths of mpox cases had serological evidence of one or more STIs.
Nigeriampox · STIsobservé 2017-2019publié 2023BMJ global healthPubMeddocument de 11 observations
22 %In a case series of 50 French male individuals with confirmed monkeypox, a lower proportion of positive blood and urine samples (22–31%) was found at diagnosis.
NigeriampoxHAL · Unilimdocument de 102 observations
20,8 %The case fatality rate among HIV-positive mpox cases was 20.8% (5/24).
Nigeriampox · VIH/sidaobservé 2017-2019publié 2023BMJ global healthPubMeddocument de 11 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.